Abstract:B cells arise from the bone marrow and differentiate into various functional subsets in the peripheral lymphoid organs and inflammatory sites. Whereas T cells have been recognized as the dominant immune population in the tumor microenvironment, increasing evidence has shown the involvement of B cells in cancer development [1]. Within tertiary lymphoid structures (TLSs), which consist of aggregates of spatially organized immune cells in tumors, B cells actively interact with other populations and promote immunotherapy responses [1, 2]. However, the cellular heterogeneity, functional diversity, and underlying mechanisms of B-cell subsets across diverse cancer types remain major challenges for dissecting the roles of B cells in tumor development and immunotherapies. In newly published papers in Science and Cell , two research groups independently established pancancer landscapes of tumor-infiltrating B cells across major human cancer types by integrating single-cell transcriptomes, B-cell-receptor (BCR) repertoires, chromatin accessibility data, and clinical prognostic information [3, 4]. Using public datasets and their generated single-cell RNA sequencing (scRNA-seq) data derived from cancer patients, Ma et al. identified 15 distinct B-cell subsets, whereas Yang et al. discovered a total of 20 fine-grained B-cell subpopulations, both of which showed significant tissue and cancer-type preferences. These two studies successfully characterized major B-cell subsets during different maturation stages, including naïve B cells, pre-germinal center and germinal center (GC)B cells, memory B cells, and plasma cells, on the basis of their hallmark gene expression signatures. Notably, they revealed the molecular phenotypes and functional features of novel B-cell subsets, including stressed B cells and tumor-associated atypical B (TAAB) cells, across cancer types. These novel findings revealed the existence of diverse functional B-cell subsets at the pancancer level and their associations with the clinical prognosis of cancer patients.

New insights into B cells as antigen presenting cells

Role of B cells as antigen presenting cells

B-cell Receptor Repertoire Sequencing: Deeper Digging into the Mechanisms and Clinical Aspects of Immune-Mediated Diseases

The role of B lymphocytes as antigen-presenting cells

An Overview of B-1 Cells as Antigen-Presenting Cells

Understanding the cell biology of antigen presentation: the dendritic cell contribution.

B Cells in Primitive Vertebrate Act As Pivotal Antigen Presenting Cells in Priming Adaptive Immunity (P5035)

Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses

Early BCR Events and Antigen Capture, Processing, and Loading on MHC Class II on B Cells

BCR Selection and Affinity Maturation in Peyer’s Patch Germinal Centres

Both sides now: evolutionary traits of antigens and B cells in tolerance and activation

MHC cross-dressing in antigen presentation

B cells: The many facets of B cells in allergic diseases

Pivotal advance: peritoneal cavity B-1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD4+ T cells.

Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis

Antigen presentation by B cells enables epitope spreading across an MHC barrier

Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade

Regulatory B cells in autoimmune diseases and mucosal immune homeostasis

A Novel Cellular Pathway of Antigen Presentation and CD4 T Cell Activation in vivo

The emerging roles of B cells in cancer development

Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies